NFKB1 and gastric cancer: NF-κB signaling pathway was a well-known tumor-promoting tunnel [30, 31], which was blocked after lidocaine treatment, indicating that lidocaine played the anti-gastric cancer role partly by down-regulating NF-κB pathway.